Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−88.8403 USD
−37.41 M USD
58.47 K USD
3.50 M
About Onconetix, Inc.
Sector
CEO
Ralph Schiess
Headquarters
Cincinnati
Website
Founded
2018
FIGI
BBG00PNSYQJ2
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company was founded in October 2018 and is headquartered in Cincinnati, OH.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ONCO is 0.3400 USD — it has decreased by −2.58% in the past 24 hours. Watch Onconetix, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Onconetix, Inc. stocks are traded under the ticker ONCO.
ONCO stock has fallen by −25.76% compared to the previous week, the month change is a −71.67% fall, over the last year Onconetix, Inc. has showed a −95.95% decrease.
ONCO reached its all-time high on Feb 22, 2022 with the price of 3,636.0000 USD, and its all-time low was 0.3469 USD and was reached on Dec 20, 2024. View more price dynamics on ONCO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ONCO stock is 11.58% volatile and has beta coefficient of 2.21. Track Onconetix, Inc. stock price on the chart and check out the list of the most volatile stocks — is Onconetix, Inc. there?
Today Onconetix, Inc. has the market capitalization of 2.82 M, it has decreased by −25.74% over the last week.
Yes, you can track Onconetix, Inc. financials in yearly and quarterly reports right on TradingView.
Onconetix, Inc. is going to release the next earnings report on Mar 6, 2025. Keep track of upcoming events with our Earnings Calendar.
ONCO net income for the last quarter is −3.83 M USD, while the quarter before that showed −14.31 M USD of net income which accounts for 73.25% change. Track more Onconetix, Inc. financial stats to get the full picture.
No, ONCO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 23.00 employees. See our rating of the largest employees — is Onconetix, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Onconetix, Inc. EBITDA is −13.10 M USD, and current EBITDA margin is −27.09 K%. See more stats in Onconetix, Inc. financial statements.
Like other stocks, ONCO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Onconetix, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Onconetix, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Onconetix, Inc. stock shows the sell signal. See more of Onconetix, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.